Free Trial

ANIXA BIOSCIENCES (ANIX) Competitors

ANIXA BIOSCIENCES logo
$3.22 -0.15 (-4.45%)
Closing price 04:00 PM Eastern
Extended Trading
$3.30 +0.08 (+2.48%)
As of 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ANIX vs. CMPX, AQST, ITOS, ETON, VIGL, HUMA, CYRX, ATXS, CKPT, and ARCT

Should you be buying ANIXA BIOSCIENCES stock or one of its competitors? The main competitors of ANIXA BIOSCIENCES include Compass Therapeutics (CMPX), Aquestive Therapeutics (AQST), iTeos Therapeutics (ITOS), Eton Pharmaceuticals (ETON), Vigil Neuroscience (VIGL), Humacyte (HUMA), CryoPort (CYRX), Astria Therapeutics (ATXS), Checkpoint Therapeutics (CKPT), and Arcturus Therapeutics (ARCT). These companies are all part of the "pharmaceutical products" industry.

ANIXA BIOSCIENCES vs. Its Competitors

Compass Therapeutics (NASDAQ:CMPX) and ANIXA BIOSCIENCES (NASDAQ:ANIX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.

Compass Therapeutics' return on equity of -42.47% beat ANIXA BIOSCIENCES's return on equity.

Company Net Margins Return on Equity Return on Assets
Compass TherapeuticsN/A -42.47% -38.31%
ANIXA BIOSCIENCES N/A -68.17%-60.38%

Compass Therapeutics has a beta of 1.48, indicating that its stock price is 48% more volatile than the S&P 500. Comparatively, ANIXA BIOSCIENCES has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500.

68.4% of Compass Therapeutics shares are held by institutional investors. Comparatively, 29.1% of ANIXA BIOSCIENCES shares are held by institutional investors. 29.8% of Compass Therapeutics shares are held by insiders. Comparatively, 25.3% of ANIXA BIOSCIENCES shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, ANIXA BIOSCIENCES had 4 more articles in the media than Compass Therapeutics. MarketBeat recorded 5 mentions for ANIXA BIOSCIENCES and 1 mentions for Compass Therapeutics. Compass Therapeutics' average media sentiment score of 1.89 beat ANIXA BIOSCIENCES's score of 1.32 indicating that Compass Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Compass Therapeutics Very Positive
ANIXA BIOSCIENCES Positive

ANIXA BIOSCIENCES has lower revenue, but higher earnings than Compass Therapeutics. ANIXA BIOSCIENCES is trading at a lower price-to-earnings ratio than Compass Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Compass Therapeutics$850K517.33-$49.38M-$0.41-7.76
ANIXA BIOSCIENCES$210K493.89-$12.55M-$0.38-8.47

Compass Therapeutics presently has a consensus price target of $12.67, indicating a potential upside of 298.32%. ANIXA BIOSCIENCES has a consensus price target of $9.00, indicating a potential upside of 179.50%. Given Compass Therapeutics' higher possible upside, research analysts clearly believe Compass Therapeutics is more favorable than ANIXA BIOSCIENCES.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Compass Therapeutics
0 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
3.10
ANIXA BIOSCIENCES
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25

Summary

Compass Therapeutics beats ANIXA BIOSCIENCES on 10 of the 14 factors compared between the two stocks.

Get ANIXA BIOSCIENCES News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ANIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ANIX vs. The Competition

MetricANIXA BIOSCIENCESMED IndustryMedical SectorNASDAQ Exchange
Market Cap$108.55M$3.03B$5.74B$9.51B
Dividend YieldN/A2.40%4.60%3.99%
P/E RatioN/A21.1828.1120.03
Price / Sales493.89339.44461.57200.15
Price / CashN/A43.2336.5559.01
Price / Book5.468.368.655.90
Net Income-$12.55M-$55.19M$3.25B$258.66M
7 Day Performance-6.40%5.89%4.20%2.23%
1 Month Performance-2.72%17.63%10.82%12.76%
1 Year Performance11.42%5.09%34.70%19.36%

ANIXA BIOSCIENCES Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ANIX
ANIXA BIOSCIENCES
3.1012 of 5 stars
$3.22
-4.5%
$9.00
+179.5%
+21.7%$108.55M$210K0.005Positive News
CMPX
Compass Therapeutics
3.025 of 5 stars
$2.92
+8.1%
$12.67
+333.8%
+230.9%$403.79M$850K-7.1220Positive News
AQST
Aquestive Therapeutics
1.7086 of 5 stars
$4.03
+0.5%
$10.14
+151.7%
+24.6%$400.30M$57.56M-6.83160
ITOS
iTeos Therapeutics
3.18 of 5 stars
$10.35
+0.6%
$15.86
+53.2%
-38.1%$396.09M$35M-3.4090News Coverage
Analyst Revision
ETON
Eton Pharmaceuticals
2.1782 of 5 stars
$14.54
+0.3%
$29.67
+104.0%
+333.0%$389.96M$39.01M-80.7820Positive News
VIGL
Vigil Neuroscience
3.9363 of 5 stars
$8.07
+0.2%
$10.80
+33.8%
+89.4%$384.83MN/A-3.9440Positive News
HUMA
Humacyte
1.6564 of 5 stars
$2.47
+6.9%
$11.71
+374.3%
-66.9%$383.14M$517K-3.58150News Coverage
Analyst Forecast
CYRX
CryoPort
1.7838 of 5 stars
$7.50
-0.7%
$10.88
+45.0%
-7.0%$376.05M$228.38M-3.211,186
ATXS
Astria Therapeutics
1.9456 of 5 stars
$6.62
+3.9%
$30.00
+353.2%
-42.8%$373.57MN/A-3.5430Positive News
CKPT
Checkpoint Therapeutics
0.3066 of 5 stars
$4.26
flat
$4.33
+1.7%
N/A$370.71M$41K-2.3210
ARCT
Arcturus Therapeutics
2.1639 of 5 stars
$13.31
-3.4%
$54.00
+305.7%
-33.2%$360.98M$131.27M-5.26180

Related Companies and Tools


This page (NASDAQ:ANIX) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners